-
2
-
-
0032902360
-
Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women
-
Berl
-
Richardson MA, Reilly MA, Read LL, Flynn CJ, Suckow RF, Maher TJ, Sziraki I: Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women. Psychopharmacology (Berl) 1999; 143:347-357
-
(1999)
Psychopharmacology
, vol.143
, pp. 347-357
-
-
Richardson, M.A.1
Reilly, M.A.2
Read, L.L.3
Flynn, C.J.4
Suckow, R.F.5
Maher, T.J.6
Sziraki, I.7
-
3
-
-
0024402705
-
The plasma phenylalanine/large neutral amino acid ratio: A risk factor for tardive dyskinesia
-
Richardson MA, Suckow R, Whittaker R, Boggiano W, Sziraki I, Kushner H, Perumal A: The plasma phenylalanine/large neutral amino acid ratio: a risk factor for tardive dyskinesia. Psychopharmacol Bull 1989; 25:47-51
-
(1989)
Psychopharmacol Bull
, vol.25
, pp. 47-51
-
-
Richardson, M.A.1
Suckow, R.2
Whittaker, R.3
Boggiano, W.4
Sziraki, I.5
Kushner, H.6
Perumal, A.7
-
4
-
-
0013551434
-
A dietary intervention decreases tardive dyskinesia symptoms
-
Washington, DC, American Psychiatric Association
-
Richardson MA, Bevans M, Weber J, Gonzalez J, Flynn C, Amira L: A dietary intervention decreases tardive dyskinesia symptoms, in 1996 Annual Meeting Syllabus and Proceedings Summary. Washington, DC, American Psychiatric Association, 1996, p 194
-
(1996)
1996 Annual Meeting Syllabus and Proceedings Summary
, pp. 194
-
-
Richardson, M.A.1
Bevans, M.2
Weber, J.3
Gonzalez, J.4
Flynn, C.5
Amira, L.6
-
5
-
-
33444456937
-
-
Treatment of Tardive Dyskinesia With Leucine, Isoleucine, Valine, or Mixtures Thereof (patent number 5,393,784). Washington, DC, US Patent and Trademark Office, 1995
-
Richardson MA: Treatment of Tardive Dyskinesia With Leucine, Isoleucine, Valine, or Mixtures Thereof (patent number 5,393,784). Washington, DC, US Patent and Trademark Office, 1995
-
-
-
Richardson, M.A.1
-
6
-
-
0032899317
-
Branched chain amino acids decrease tardive dyskinesia symptoms
-
Berl
-
Richardson MA, Bevans ML, Weber JB, Gonzalez JJ, Flynn CJ, Amira L, Read LL, Suckow RF, Maher TJ: Branched chain amino acids decrease tardive dyskinesia symptoms. Psychopharmacology (Berl) 1999; 143:358-364
-
(1999)
Psychopharmacology
, vol.143
, pp. 358-364
-
-
Richardson, M.A.1
Bevans, M.L.2
Weber, J.B.3
Gonzalez, J.J.4
Flynn, C.J.5
Amira, L.6
Read, L.L.7
Suckow, R.F.8
Maher, T.J.9
-
8
-
-
0026439134
-
Effect of branched-chain amino acid supplementation on the exercise-induced change in aromatic amino acid concentration in human muscle
-
Blomstrand E, Newsholme EA: Effect of branched-chain amino acid supplementation on the exercise-induced change in aromatic amino acid concentration in human muscle. Acta Physiol Scand 1992; 146:293-298
-
(1992)
Acta Physiol Scand
, vol.146
, pp. 293-298
-
-
Blomstrand, E.1
Newsholme, E.A.2
-
9
-
-
33444458696
-
Alterations in protein kinetics produced by branched chain amino acid administration during infection and inflammation
-
Edited by Walser M, Williamson JR. New York, Elsevier-North Holland
-
Moldawer LL, Sakamoto A, Blackburn GL, Bistrian BR: Alterations in protein kinetics produced by branched chain amino acid administration during infection and inflammation, in Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Edited by Walser M, Williamson JR. New York, Elsevier-North Holland, 1981, pp 533-539
-
(1981)
Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids
, pp. 533-539
-
-
Moldawer, L.L.1
Sakamoto, A.2
Blackburn, G.L.3
Bistrian, B.R.4
-
10
-
-
0001688801
-
Branched-chain amino and keto acids as regulators of insulin and glucagon release
-
Edited by Adibi SA, Fekl W, Langenbeck U, Schauder P. Basel, Karger
-
Malaisse WJ: Branched-chain amino and keto acids as regulators of insulin and glucagon release, in Branched-Chain Amino and Keto Acids in Health and Disease. Edited by Adibi SA, Fekl W, Langenbeck U, Schauder P. Basel, Karger, 1984, pp 119-133
-
(1984)
Branched-Chain Amino and Keto Acids in Health and Disease
, pp. 119-133
-
-
Malaisse, W.J.1
-
11
-
-
0025201970
-
Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man
-
Louard RJ, Barrett EJ, Gelfand RA: Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. Clin Sci 1990; 79:457-466
-
(1990)
Clin Sci
, vol.79
, pp. 457-466
-
-
Louard, R.J.1
Barrett, E.J.2
Gelfand, R.A.3
-
12
-
-
0013509257
-
Plasma branched-chain amino acids as regulators of brain neurotransmitters
-
Edited by Adibi SA, Fekl W, Langenbeck U, Schauder P. Basel, Karger
-
Maher TJ: Plasma branched-chain amino acids as regulators of brain neurotransmitters, in Branched-Chain Amino and Keto Acids in Health and Disease. Edited by Adibi SA, Fekl W, Langenbeck U, Schauder P. Basel, Karger, 1984, pp 242-259
-
(1984)
Branched-Chain Amino and Keto Acids in Health and Disease
, pp. 242-259
-
-
Maher, T.J.1
-
13
-
-
0025150823
-
Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: A randomized double-blind casein-controlled trial
-
Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, Marlines D, Abbiati R: Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: a randomized double-blind casein-controlled trial. J Hepatol 1990; 11:92-101
-
(1990)
J Hepatol
, vol.11
, pp. 92-101
-
-
Marchesini, G.1
Dioguardi, F.S.2
Bianchi, G.P.3
Zoli, M.4
Bellati, G.5
Roffi, L.6
Marlines, D.7
Abbiati, R.8
-
15
-
-
0021242473
-
Prevalence of tardive dyskinesia in elderly samples
-
Lieberman J, Kane JM, Woerner M, Weinhold P, Basavaraju N, Kurucz J, Bergmann K: Prevalence of tardive dyskinesia in elderly samples. Psychopharmacol Bull 1984; 20:382-386
-
(1984)
Psychopharmacol Bull
, vol.20
, pp. 382-386
-
-
Lieberman, J.1
Kane, J.M.2
Woerner, M.3
Weinhold, P.4
Basavaraju, N.5
Kurucz, J.6
Bergmann, K.7
-
16
-
-
0020084370
-
The coexistence of parkinsonism-like symptoms and tardive dyskinesia
-
Richardson MA, Craig TJ: The coexistence of parkinsonism-like symptoms and tardive dyskinesia. Am J Psychiatry 1982; 139:341-343
-
(1982)
Am J Psychiatry
, vol.139
, pp. 341-343
-
-
Richardson, M.A.1
Craig, T.J.2
-
18
-
-
0020050047
-
Intra-patient variability in the measurement of tardive dyskinesia
-
Berl
-
Richardson MA, Craig TJ, Branchey MH: Intra-patient variability in the measurement of tardive dyskinesia. Psychopharmacology (Berl) 1982; 76:269-272
-
(1982)
Psychopharmacology
, vol.76
, pp. 269-272
-
-
Richardson, M.A.1
Craig, T.J.2
Branchey, M.H.3
-
19
-
-
9344245871
-
Methodological approach to the measurement of tardive dyskinesia: Piezoelectric recording and concurrent validity test of five clinical rating scales
-
Edited by Fann WE, Smith RC, Davis JM, Domino EF. New York, SP Medical and Scientific Books
-
Chien C, Jung K, Ross-Townsend A: Methodological approach to the measurement of tardive dyskinesia: piezoelectric recording and concurrent validity test of five clinical rating scales, in Tardive Dyskinesia Research and Treatment. Edited by Fann WE, Smith RC, Davis JM, Domino EF. New York, SP Medical and Scientific Books, 1980, pp 233-241
-
(1980)
Tardive Dyskinesia Research and Treatment
, pp. 233-241
-
-
Chien, C.1
Jung, K.2
Ross-Townsend, A.3
-
22
-
-
0015364024
-
Treatment of tardive dyskinesia, I: Clinical efficacy of a dopamine-depleting agent, tetrabenazine
-
Kazamatsuri H, Chien C, Cole JO: Treatment of tardive dyskinesia, I: clinical efficacy of a dopamine-depleting agent, tetrabenazine. Arch Gen Psychiatry 1972; 27:95-99
-
(1972)
Arch Gen Psychiatry
, vol.27
, pp. 95-99
-
-
Kazamatsuri, H.1
Chien, C.2
Cole, J.O.3
-
23
-
-
33444467097
-
Tardive dyskinesia five-year outcome: A descriptive analysis
-
Bethesda, Md, National Institute of Mental Health, NCDEU
-
Richardson MA, Casey DE, Lin SP: Tardive dyskinesia five-year outcome: a descriptive analysis, in Abstracts of the 1989 Meeting of the New Clinical Drug Evaluation Unit. Bethesda, Md, National Institute of Mental Health, NCDEU, 1989
-
(1989)
Abstracts of the 1989 Meeting of the New Clinical Drug Evaluation Unit
-
-
Richardson, M.A.1
Casey, D.E.2
Lin, S.P.3
-
24
-
-
0024246342
-
Tardive dyskinesia status: Stability or change
-
Richardson MA, Casey DE: Tardive dyskinesia status: stability or change. Psychopharmacol Bull 1988; 24:471-475
-
(1988)
Psychopharmacol Bull
, vol.24
, pp. 471-475
-
-
Richardson, M.A.1
Casey, D.E.2
-
25
-
-
0034849589
-
6 in the treatment of tardive dyskinesia: A double-blind, placebo-controlled, crossover study
-
6 in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Am J Psychiatry 2001; 158:1511-1514
-
(2001)
Am J Psychiatry
, vol.158
, pp. 1511-1514
-
-
Lerner, V.1
Miodownik, C.2
Kaptsan, A.3
Cohen, H.4
Matar, M.5
Loewenthal, U.6
Kotler, M.7
-
26
-
-
0033973363
-
Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia
-
Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD: Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Am J Psychiatry 2000; 157:287-289
-
(2000)
Am J Psychiatry
, vol.157
, pp. 287-289
-
-
Sirota, P.1
Mosheva, T.2
Shabtay, H.3
Giladi, N.4
Korczyn, A.D.5
-
27
-
-
0003658949
-
-
Cary, NC, SAS Institute
-
SAS Version 8.1. Cary, NC, SAS Institute, 1999
-
(1999)
SAS Version 8.1
-
-
-
28
-
-
0017654351
-
Pharmacological characterization of tardive dyskinesia
-
Berl
-
Casey DE, Denney D: Pharmacological characterization of tardive dyskinesia. Psychopharmacology (Berl) 1977; 54:1-8
-
(1977)
Psychopharmacology
, vol.54
, pp. 1-8
-
-
Casey, D.E.1
Denney, D.2
-
29
-
-
0023758706
-
Pharmacologic studies of tardive dyskinesia
-
Lieberman J, Lesser M, Johns C, Pollack S, Saltz B, Kane J: Pharmacologic studies of tardive dyskinesia. J Clin Psychopharmacol 1988; 8(suppl):57S-63S
-
(1988)
J Clin Psychopharmacol
, vol.8
, Issue.SUPPL.
-
-
Lieberman, J.1
Lesser, M.2
Johns, C.3
Pollack, S.4
Saltz, B.5
Kane, J.6
-
31
-
-
0026666282
-
Gender differences in tardive dyskinesia: A critical review of the literature
-
Yassa R, Jeste DV: Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 1992; 18:701-715
-
(1992)
Schizophr Bull
, vol.18
, pp. 701-715
-
-
Yassa, R.1
Jeste, D.V.2
-
34
-
-
0025853254
-
Plasma amino acid concentrations in healthy elderly men and women
-
Caballero B, Gleason RE, Wurtman RJ: Plasma amino acid concentrations in healthy elderly men and women. Am J Clin Nutr 1991; 53:1249-1252
-
(1991)
Am J Clin Nutr
, vol.53
, pp. 1249-1252
-
-
Caballero, B.1
Gleason, R.E.2
Wurtman, R.J.3
-
35
-
-
0022967066
-
Plasma free amino acid values in normal children and adolescents
-
Gregory DM, Sovetts D, Clow CL, Scriver CR: Plasma free amino acid values in normal children and adolescents. Metabolism 1986; 35:967-969
-
(1986)
Metabolism
, vol.35
, pp. 967-969
-
-
Gregory, D.M.1
Sovetts, D.2
Clow, C.L.3
Scriver, C.R.4
-
36
-
-
0024558679
-
Influence of gender and menopause on gastric emptying and motility
-
Hutson WR, Roehrkasse RL, Wald A: Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989; 96:11-17
-
(1989)
Gastroenterology
, vol.96
, pp. 11-17
-
-
Hutson, W.R.1
Roehrkasse, R.L.2
Wald, A.3
-
37
-
-
33444473969
-
Branched chain amino acids and inborn errors of metabolism
-
Edited by Kinney JM, Borum PR. Baltimore, Urban & Schwarzenburg
-
Berry HK: Branched chain amino acids and inborn errors of metabolism, in Perspectives in Clinical Nutrition. Edited by Kinney JM, Borum PR. Baltimore, Urban & Schwarzenburg, 1989, pp 207-218
-
(1989)
Perspectives in Clinical Nutrition
, pp. 207-218
-
-
Berry, H.K.1
-
38
-
-
0019959175
-
Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine and leucine
-
Berry HK, Bofinger MK, Hunt MM, Phillips PJ, Guilfaile MB: Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine and leucine. Pediatr Res 1982; 16:751-755
-
(1982)
Pediatr Res
, vol.16
, pp. 751-755
-
-
Berry, H.K.1
Bofinger, M.K.2
Hunt, M.M.3
Phillips, P.J.4
Guilfaile, M.B.5
-
39
-
-
0033560647
-
Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria
-
Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ: Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 1999; 103:1169-1178
-
(1999)
J Clin Invest
, vol.103
, pp. 1169-1178
-
-
Pietz, J.1
Kreis, R.2
Rupp, A.3
Mayatepek, E.4
Rating, D.5
Boesch, C.6
Bremer, H.J.7
-
40
-
-
0344765524
-
Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria
-
Moller HE, Weglage J, Wiedermann D, Ullrich K: Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria. J Cereb Blood Flow Metab 1998; 18:1184-1191
-
(1998)
J Cereb Blood Flow Metab
, vol.18
, pp. 1184-1191
-
-
Moller, H.E.1
Weglage, J.2
Wiedermann, D.3
Ullrich, K.4
|